EVALUATION AND IMPACT OF PHARMACIST INTERVENTION ON PATIENTS WITH DEPRESSION IN A TERTIARY CARE HOSPITAL OF HYDERABAD, PAKISTAN.
Main Article Content
Keywords
Depression; Pharmacist Intervention; PHQ-9; Medication Adherence; Mental Health; Tertiary Care; Pakistan
Abstract
Background:
Depression is a leading cause of disability worldwide and a growing public health challenge in low- and middle-income countries, including Pakistan. High prevalence, coupled with poor treatment adherence and limited specialist availability, underscores the need for innovative care models. Pharmacist-led interventions may offer a feasible solution for improving outcomes.
Objectives:
To evaluate the prevalence and severity of depression, identify associated demographic and lifestyle factors and assess the impact of pharmacist-led counseling on depressive symptoms and medication adherence.
Methods:
The study was conducted at Liaquat University Hospital, a tertiary care teaching hospital in Hyderabad, Pakistan. A total of 670 patients were screened using the PHQ-9 scale, of whom 377 were identified with depression. Data on demographics, clinical variables and adherence were collected at baseline. Pharmacist counseling sessions focused on education, medication adherence and lifestyle modification. Outcomes were assessed using PHQ-9 and adherence scores before and after intervention. Statistical analyses included chi-square tests, paired t-tests and McNemar’s test, with significance set at p<0.05.
Results:
Depression was diagnosed in 56.3% of patients, with severity distributed as mild (23.1%), moderate (25.5%) and severe (51.5%). Significant associations were observed with female gender, middle age, unemployment, smoking and inpatient status. The mean PHQ-9 score decreased from b post-intervention (p<0.001; Cohen’s d=0.52). Severe cases reduced from 51.5% to 23.6% while 9.0% achieved remission. Inpatients showed greater improvement than outpatients (–3.4 vs –2.1 points, both p<0.001). Medication adherence improved from 47.8% to 71.3%, with significant gains across all severity levels (p<0.001).
Conclusion:
Pharmacist intervention positively impacted depressive symptoms and medication adherence in patients in a tertiary care hospital. These outcomes point to the importance of embedding pharmacists in multidisciplinary teams in mental care to cover these gaps in the treatment of resources in the low-resource environment.
References
2. Shah SM, Akhtar O, Haq UU, Asghar S, Ghafoor NA, Abbas SZ. Integrating Mental Health Support in Pharmacy Practice: Assessing the Impact of Pharmacist-Led Interventions on Anxiety and Depression Outcomes. Open Access Public Health and Health Administration Review. 2025;3(2):56-74.
3. Khan FU, Khan FU, Aqeel MT, Hayat K, Chang J, Rehman AU, Fang Y. A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients. Frontiers in Pharmacology. 2023 May 24; 14:1171985.
4. Riaz S, Khuda F, Malik NS, Gohar N, Rashid A, Khan A, Rahman A, Ali S, Jan A, Nasim A. Cross-cultural adaptation and psychometric evaluation of the urdu version of the morisky, greene and levine medication adherence scale (MGLS-4) for major depressive disorder patients. PLoS One. 2025 Apr 28;20(4): e0320258.
5. Arshed M, Umer MF, Kiran M, Akhter AM, Gillani AH, Qamer S, Kawish AB, Zofeen S, Farid A, Khan MN. Prevalence and associated factors of non-adherence to antihyperlipidemic medication: a nationwide cross-sectional survey in Pakistan. Scientific Reports. 2024 Sep 4;14(1):20613.
6. Zheng Y, Liu J, Tang PK, Hu H, Ung CO. A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharmacy practice in supporting public health measures. Frontiers in Public Health. 2023 Jun 15; 11:1184882.
7. Singh K, Kondal D, Menon VU, Varthakavi PK, Viswanathan V, Dharmalingam M, Bantwal G, Sahay RK, Masood MQ, Khadgawat R, Desai A. Cost‐effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial. Diabetic Medicine. 2023 Sep;40(9): e15074.
8. Saeed A, Sughra U, Noor F, Ahmad I, Farooq U, Nazir T. Impact of pharmacist led pharmaceutical care on patient medication therapy using prompt-qol in tertiary care hospital: a randomized controlled trial. J Appl Pharm. 2021; 13:1-3.
9. Salazar LJ, Srinivasan K, Heylen E, Ekstrand ML. Medication Adherence among primary care patients with common mental disorders and chronic medical conditions in rural India. Indian Journal of Psychological Medicine. 2023 Nov;45(6):622-8.
10. Khanal K. A STUDY OF PRESCRIPTION PROVIDED TO THE ELDERLY; USING WHO PRESCRIBING INDICATORS AND BEERS CRITERIA.
11. Paudel N, Shrestha S, Marasine NR, Khanal P, Aryal S, Erku D, Poudel A. Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial. European Journal of Hospital Pharmacy. 2023 Nov 1;30(6):316-21.
12. Khan FU, Khan FU, Aqeel MT, Hayat K, Chang J, Rehman AU, Fang Y. A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients. Frontiers in Pharmacology. 2023 May 24; 14:1171985.
13. Kirubarajan A, Lam A, Yu A, Taheri C, Khan S, Sethuram C, Mehta V, Olivieri N. Knowledge, information sources and institutional trust of patients regarding medication use in pregnancy: a systematic review. Journal of Family & Reproductive Health. 2021 Sep;15(3):160.
14. Noor R. Meeting WHO’s Conditions for Labor Augmentation: A Narrative Literature Review on South Asia and A linked Analysis Using DHS 2016 and SPA 2015 Surveys in Nepal.
15. Mishra A, Kishor MR, Ramesh M. Randomized controlled trial to assess medication adherence and health-related quality of life through a collaborative pharmacist-psychiatrist approach to patient education in patients with depression in India. Frontiers in Psychiatry. 2025 Feb 25; 16:1499893.
16. Okenwa SC, Ekweozor CA, Eze I, Nwankwo FM, Nwachukwu JC, Anunwa IG, Nwiyi CJ, Ejike LC. Assessing socioeconomic disparities and health outcomes among cancer patients in a Nigerian teaching hospital. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2024 Nov 5;13(4):61-73.
17. Marasine NR, Sankhi S, Lamichhane R. Impact of pharmacist intervention on medication adherence and patient-reported outcomes among depressed patients in a private psychiatric hospital of Nepal: a randomised controlled trial. Hospital Pharmacy. 2022 Feb;57(1):26-31.
18. Bunchuailua W, Samprasit N, Kotirum S, Kapol N. Impact of pharmacist activities in patients with depression: a systematic review and meta-analysis of randomized controlled trials. Annals of Pharmacotherapy. 2022 May;56(5):556-64.
19. Sunny S, Prabhu S, Chand S, UP N, Chacko CS, Joel JJ. Assessment of drug-drug interactions among patients with psychiatric disorders: a clinical pharmacist-led study. Clinical Epidemiology and Global Health. 2022 Jan 1; 13:100930.
20. Eshiet UI, Okonta JM, Ukwe CV. Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: a randomized controlled trial. Epilepsy Research. 2021 Aug 1; 174:106648.
21. Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, Suansanae T. Impact of pharmacist-physician collaboration on patient outcomes in Parkinson’s disease: a randomised controlled trial in tertiary care. International Journal of Clinical Pharmacy. 2025 Jun;47(3):834-43.